InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 13.72
-0.33 (-2.35%)
Apr 29, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 28.40 billion as of April 29, 2026. Its market cap has increased by 51.49% in one year.
Market Cap
28.40B
Enterprise Value
22.10B
Revenue
2.87B
Ranking
n/a
PE Ratio
28.48
Stock Price
13.72
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 28.40B, an increase of 131.31%. That is a compound annual growth rate of 14.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 29.78B |
| Shanghai Bao Pharmaceuticals | 26.78B |
| Duality Biotherapeutics | 25.45B |
| TransThera Sciences (Nanjing) | 23.21B |
| Keymed Biosciences | 22.29B |
| Zai Lab | 19.27B |
| Ascletis Pharma | 19.00B |
| Shanghai Junshi Biosciences | 42.68B |